MAT Tools and Resources

This brief describes research documenting the added challenges stimulant use contributes to those who use opioids and patient-centered approaches for working with people who use stimulants that are enrolled in medication treatment for opioid use disorder.

This brief reviews opioid and stimulant trends in availability, use, and impacts; compares opioids and stimulants in terms of drug effects and motivations for use; and examines the factors that drive co-use.

This guide describes relevant research findings, examines best practices, identifies knowledge gaps and implementation challenges, and offers useful resources for treating stimulant use disorders.

This toolkit offers high-level strategies for integrating The American Society of Addiction Medicine Criteria into a state’s approach to SUD services, as well as potential pathways, implementation vehicles, state examples, model legislative, regulatory, and contractual language.

This module offers practical considerations for buprenorphine initiation, dosing, and ongoing patient management and explores the core principles of opioid use disorder treatment and the importance of language when treating patients with this condition.

This guide provides considerations and strategies for clinicians and organizations implementing evidence-based practices. Approaches presented will assist clinicians, behavioral health organizations, primary care providers, insurers, and policy makers in understanding, selecting, and implementing evidence-based interventions that support adults with concurrent substance use and/or concurrent substance use disorders, including alcohol.

This free, 1-hour, online training course provides evidence-based coping strategies, resources, and exercises to help mitigate the mental and physical stressors of the opioid crisis on first responders.

This brief explores COVID-19 policy changes related to access to medications for opioid use disorder and recommends changes to keep in place beyond the emergency period.

This “how-to” guide provides physician practices and health systems with practical strategies, actionable steps and evidence-based resources for identifying and addressing unhealthy substance use or misuse in their patients.

These guidelines provide eligible clinicians who are state licensed and registered by the DEA to prescribe controlled substances, an exemption from certain statutory certification requirements related to training, counseling and other ancillary services.